CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTMX CytomX

交易中 11-22 12:54:21 EST

0.8825

+0.0160

+1.85%

最高0.8950	最低0.8600	成交量27.80万
今开0.8900	昨收0.8665	日振幅4.04%
总市值6,906万	流通市值5,867万	总股本7,826万
成交额24.49万	换手率0.42%	流通股本6,649万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTMX","market":"US","secType":"STK","nameCN":"CytomX","latestPrice":0.8825,"timestamp":1732298004051,"preClose":0.8665,"halted":0,"volume":277989,"delay":0,"floatShares":66485206,"shares":78258879,"eps":0.161506,"marketStatus":"交易中","marketStatusCode":2,"change":0.016,"latestTime":"11-22 12:54:21 EST","open":0.89,"high":0.895,"low":0.86,"amount":244869.43223834998,"amplitude":0.040392,"askPrice":0.8886,"askSize":142,"bidPrice":0.8818,"bidSize":102,"shortable":3,"etf":0,"ttmEps":0.161506,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1444276800000,"adjPreClose":0.8665,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.89,"preClose":0.8665,"latestTime":"09:27 EST","volume":11823,"amount":10510.492709850001,"timestamp":1732285670190},"postHourTrading":{"tag":"盘后","latestPrice":0.885,"preClose":0.8665,"latestTime":"19:13 EST","volume":3347,"amount":2904.4409,"timestamp":1732234429420},"volumeRatio":0.564698,"impliedVol":1.1999,"impliedVolPercentile":0.3175},"requestUrl":"/m/hq/s/CTMX","defaultTab":"news","newsList":[{"id":"2484920176","title":"Cytomx Therapeutics, Inc.盘中异动 股价大涨6.26%报0.917美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484920176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484920176?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:59","pubTimestamp":1732035579,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时59分，Cytomx Therapeutics, Inc.股票出现波动，股价急速拉升6.26%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Syros Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为819.73%、578.64%、128.05%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为91.10%、81.67%、62.18%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120005940abcfaa9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120005940abcfaa9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2484674567","title":"Cytomx Therapeutics, Inc.盘中异动 股价大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674567?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:04","pubTimestamp":1731942265,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时04分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅下挫5.57%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为553.10%、458.67%、322.30%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.81%、72.26%、71.83%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230425971a733d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230425971a733d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2484543619","title":"Cytomx Therapeutics, Inc.2024财年第三财季实现净利润5.74百万美元，同比增加91.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484543619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484543619?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773097,"startTime":"0","endTime":"0","summary":"11月17日，Cytomx Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为5.74百万美元，同比增加91.97%；其中营业收入为33.43百万美元，同比增加26.72%，每股基本收益为0.07美元。从资产负债表来看，Cytomx Therapeutics, Inc.总负债1.62亿美元，其中短期债务5.00百万美元，资产负债比为0.86，流动比率为1.05。机构评级：截至2024年11月17日，当前有5家机构对Cytomx Therapeutics, Inc.目标价做出预测，其中目标均价为5.29美元，其中最低目标价为3.25美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000636abc79248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000636abc79248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX"],"gpt_icon":0},{"id":"2481101911","title":"Cytomx Therapeutics, Inc.盘中异动 股价大涨15.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101911?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076445,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Cytomx Therapeutics, Inc.股票出现波动，股价急速上涨15.00%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为395.92%、16.85%、14.88%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822340695bdef72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822340695bdef72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTMX"],"gpt_icon":0},{"id":"2481617400","title":"CytomX Therapeutics Inc    预计每股亏损 17 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481617400","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481617400?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:23","pubTimestamp":1730870622,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于11月7日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收将从去年同期的2638万美元下降33.6%，至1751.4万美元。* LSEG 分析师对 CytomX Therapeutics Inc 的平均预期是每股亏损 17 美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.56 美元，高于上一次 0.99 美元的收盘价。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2481445537","title":"Cytomx Therapeutics, Inc.盘中异动 快速下跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481445537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481445537?lang=zh_cn&edition=full","pubTime":"2024-11-05 02:06","pubTimestamp":1730743594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日02时06分，Cytomx Therapeutics, Inc.股票出现波动，股价急速下挫5.48%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为403.85%、282.01%、83.73%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为52.25%、45.39%、43.11%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105020634971a43a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105020634971a43a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX","BK4139"],"gpt_icon":0},{"id":"2480890743","title":"CytomX Therapeutics Inc    预计每股亏损 17 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480890743","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480890743?lang=zh_cn&edition=full","pubTime":"2024-11-02 11:52","pubTimestamp":1730519568,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于11月7日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收将从去年同期的2638万美元下降33.6%，至1751.4万美元。* LSEG 分析师对 CytomX Therapeutics Inc 的平均预期是每股亏损 17 美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.56 美元，高于其上次收盘价 1.05 美元。11月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CTMX"],"gpt_icon":0},{"id":"2478796647","title":"Cytomx Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478796647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478796647?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:59","pubTimestamp":1729886388,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时59分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅跳水5.09%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为878.28%、800.23%、452.19%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX","BK4139"],"gpt_icon":0},{"id":"2477353822","title":"Cytomx Therapeutics, Inc.盘中异动 股价大跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477353822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477353822?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:04","pubTimestamp":1729605841,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时04分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅下跌5.17%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3643.58%、2348.83%、1766.86%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为140.78%、99.41%、67.84%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222040198e3dc89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222040198e3dc89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CTMX"],"gpt_icon":0},{"id":"2476978929","title":"Cytomx Therapeutics, Inc.盘中异动 急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476978929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476978929?lang=zh_cn&edition=full","pubTime":"2024-10-17 03:56","pubTimestamp":1729108574,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日03时56分，Cytomx Therapeutics, Inc.股票出现异动，股价快速拉升5.36%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，180 Life Sciences Corp.、Proqr Therapeutics N.V.、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为8562.71%、2097.26%、1231.17%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd，振幅分别为745.07%、279.52%、198.41%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101703561498e3cd89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101703561498e3cd89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CTMX"],"gpt_icon":0},{"id":"2470448364","title":"Cytomx Therapeutics, Inc.盘中异动 下午盘股价大涨5.21%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470448364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470448364?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:03","pubTimestamp":1727201031,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日02时03分，Cytomx Therapeutics, Inc.股票出现波动，股价快速拉升5.21%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为4517.82%、196.16%、175.82%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.，振幅分别为122.95%、58.52%、45.08%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502035198e38b4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502035198e38b4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTMX"],"gpt_icon":0},{"id":"2469560112","title":"Cytomx Therapeutics, Inc.盘中异动 大幅下挫5.04%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469560112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469560112?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:40","pubTimestamp":1727098848,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时40分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅下跌5.04%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Pharmacyte  Biotech, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Scisparc Ltd.较为活跃，换手率分别为89.86%、25.46%、23.80%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、天演药业、Galmed Pharmaceuticals Ltd.，振幅分别为23.46%、17.72%、16.05%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923214049a1dbecbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923214049a1dbecbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTMX"],"gpt_icon":0},{"id":"2460735033","title":"Cytomx Therapeutics, Inc.2024财年第二财季实现净利润-6.53百万美元，同比减少499.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460735033","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460735033?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:03","pubTimestamp":1723910629,"startTime":"0","endTime":"0","summary":"8月18日，Cytomx Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-6.53百万美元，同比减少499.08%；其中营业收入为25.12百万美元，同比增加1.62%，每股基本收益为-0.08美元。从资产负债表来看，Cytomx Therapeutics, Inc.总负债1.90亿美元，其中短期债务4.86百万美元，资产负债比为0.84，流动比率为1.00。机构评级：截至2024年8月18日，当前有5家机构对Cytomx Therapeutics, Inc.目标价做出预测，其中目标均价为5.31美元，其中最低目标价为3.50美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800055795a1673b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800055795a1673b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX"],"gpt_icon":0},{"id":"2459142471","title":"Cytomx Therapeutics, Inc.盘中异动 早盘大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459142471","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459142471?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:09","pubTimestamp":1723734567,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时09分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅上涨5.17%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6412.65%、2054.17%、572.36%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230927ab5ddbe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230927ab5ddbe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2458592050","title":"Cytomx Therapeutics, Inc.盘中异动 早盘股价大涨6.78%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458592050","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458592050?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:45","pubTimestamp":1723214708,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时45分，Cytomx Therapeutics, Inc.股票出现异动，股价快速上涨6.78%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为68.48%、51.48%、30.37%，振幅较大的相关个股有Cingulate Inc.、An2 Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为35.31%、22.48%、22.42%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809224508aefe27cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809224508aefe27cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2457827206","title":"Cytomx Therapeutics, Inc.盘中异动 下午盘股价大跌5.16%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457827206","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457827206?lang=zh_cn&edition=full","pubTime":"2024-08-08 01:23","pubTimestamp":1723051395,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日01时23分，Cytomx Therapeutics, Inc.股票出现波动，股价快速下挫5.16%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.38%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5019.63%、1783.65%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、55.91%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080801231596824d59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080801231596824d59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTMX"],"gpt_icon":0},{"id":"2457778822","title":"Cytomx Therapeutics, Inc.盘中异动 大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457778822","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457778822?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:31","pubTimestamp":1722864708,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时31分，Cytomx Therapeutics, Inc.股票出现波动，股价快速下挫5.34%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Zevra Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为978.20%、33.14%、13.54%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Cue Biopharma, Inc.、Compass Therapeutics, Inc.，振幅分别为18.32%、12.33%、12.19%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213148941fe2f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213148941fe2f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTMX","LENZ"],"gpt_icon":0},{"id":"2456400222","title":"CytomX Therapeutics Inc    预计每股亏损 14 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456400222","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456400222?lang=zh_cn&edition=full","pubTime":"2024-08-02 20:26","pubTimestamp":1722601590,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于8月8日公布截至2024年6月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从去年同期的2472万美元下降19.1%，至19995万美元。* LSEG分析师对CytomX Therapeutics Inc的平均预期是每股亏损14美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.59 美元，高于其上次收盘价 1.34 美元。8月2日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2455662441","title":"Cytomx Therapeutics, Inc.盘中异动 股价大跌5.29%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455662441","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455662441?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:23","pubTimestamp":1722266613,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时23分，Cytomx Therapeutics, Inc.股票出现波动，股价急速下跌5.29%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大，Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2118.98%、695.39%、214.88%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为151.15%、75.11%、57.78%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729232333af94a4eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729232333af94a4eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CTMX"],"gpt_icon":0},{"id":"2453712373","title":"Cytomx Therapeutics, Inc.盘中异动 下午盘快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453712373","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453712373?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:21","pubTimestamp":1721676095,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时21分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅拉升5.07%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为123.74%、116.51%、85.54%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032135af9376c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032135af9376c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTMX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytomx.com","stockEarnings":[{"period":"1week","weight":-0.1335},{"period":"1month","weight":-0.2123},{"period":"3month","weight":-0.2839},{"period":"6month","weight":-0.5049},{"period":"1year","weight":-0.3283},{"period":"ytd","weight":-0.441}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CytomX Therapeutics, Inc.于2010年9月在特拉华州注册成立。该公司是一家临床阶段、专注于肿瘤学的生物制药公司，专注于开发旨在定位于肿瘤微环境的新型条件激活生物制剂。该公司专有、多功能、多模态的PROBODY技术平台旨在使肿瘤微环境内的生物治疗候选药物能够有条件地激活，同时最大限度地减少健康组织和循环中的药物活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098508},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007093},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.031361},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.028412},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.068706},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.024186},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.05037},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.010417},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.024094},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.090956},{"month":11,"riseRate":0.7,"avgChangeRate":0.157227},{"month":12,"riseRate":0.555556,"avgChangeRate":0.008351}],"exchange":"NASDAQ","name":"CytomX","nameEN":"CytomX Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CytomX,CTMX,CytomX股票,CytomX股票老虎,CytomX股票老虎国际,CytomX行情,CytomX股票行情,CytomX股价,CytomX股市,CytomX股票价格,CytomX股票交易,CytomX股票购买,CytomX股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}